About Richard Birkmeyer, PhD
Form D filings for Tangen Biosciences from 2019 to 2023 list Richard Birkmeyer, PhD as president and CEO, director.
Richard Birkmeyer, PhD first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Richard Birkmeyer, PhD in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Richard Birkmeyer, PhD works with at each company, as listed on that company's latest Form D.
Tangen Biosciences, Inc. · Form D, Jun 6, 2023
AL
Alan Levin
Director
VK
Vance Kershner
Director
DW
Daniel Wagner
Director
CM
Christopher McLeod
Director
JD
John Davidson
Executive officer and director